{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:46:40Z","timestamp":1790635600224,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR\/IA\/COH-2012\/3735"],"award-info":[{"award-number":["ANR\/IA\/COH-2012\/3735"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IReSP\/INSERM"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2877-x","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T08:19:22Z","timestamp":1478161162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A prospective multicenter study on bladder cancer: the COBLAnCE cohort"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1162-9165","authenticated-orcid":false,"given":"Simone","family":"Benhamou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bonastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Groussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Radvanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lebret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"2877_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013. http:\/\/globocan.iarc.fr . Accessed 25 Feb 2016"},{"key":"2877_CR2","unstructured":"World Cancer Report 2014. In: Stewart BW, Wild CP, editors. Lyon, France: International Agency for Research on Cancer; 2014. p 444\u201352"},{"key":"2877_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/carcin\/bgq223","volume":"32","author":"LE Moore","year":"2011","unstructured":"Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, et al. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis. 2011;32:182\u20139.","journal-title":"Carcinogenesis"},{"key":"2877_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ng.558","volume":"42","author":"LA Kiemeney","year":"2010","unstructured":"Kiemeney LA, Sulem P, Besenbacher S, Vermeulen SH, Sigurdsson A, Thorleifsson G, et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet. 2010;42:415\u20139.","journal-title":"Nat Genet"},{"key":"2877_CR5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/hmg\/ddt519","volume":"23","author":"JD Figueroa","year":"2014","unstructured":"Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet. 2014;23:1387\u201398.","journal-title":"Hum Mol Genet"},{"key":"2877_CR6","doi-asserted-by":"publisher","first-page":"20.e1","DOI":"10.1016\/j.urolonc.2014.09.001","volume":"33","author":"PO Bosset","year":"2015","unstructured":"Bosset PO, Neuzillet Y, Paoletti X, Molinie V, Botto H, Lebret T. Long-term follow-up of TaG1 non-muscle-invasive bladder cancer. Urol Oncol. 2015;33:20.e1\u20137.","journal-title":"Urol Oncol"},{"key":"2877_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MOU.0b013e328356ac0a","volume":"22","author":"T Lebret","year":"2012","unstructured":"Lebret T, Neuzillet Y. Indication and timing of cystectomy in high-risk bladder cancer. Curr Opin Urol. 2012;22:427\u201331.","journal-title":"Curr Opin Urol"},{"key":"2877_CR8","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/BF03262330","volume":"21","author":"MF Botteman","year":"2003","unstructured":"Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21:1315\u201330.","journal-title":"Pharmacoeconomics"},{"key":"2877_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1524-4733.2008.00489.x","volume":"12","author":"M Drummond","year":"2009","unstructured":"Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 2009;12:409\u201318.","journal-title":"Value Health"},{"key":"2877_CR10","doi-asserted-by":"publisher","first-page":"A474","DOI":"10.1016\/j.jval.2015.09.1268","volume":"18","author":"K Bartley","year":"2015","unstructured":"Bartley K, DeBusk K, Duff S. Health-related quality of life in bladder cancer: a systematic literature review. Value Health. 2015;18:A474\u20135.","journal-title":"Value Health"},{"key":"2877_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.eururo.2013.11.046","volume":"65","author":"JA Witjes","year":"2014","unstructured":"Witjes JA, Comp\u00e9rat E, Cowan NC, De Santis M, Gakis G, Lebret T, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778\u201392.","journal-title":"Eur Urol"},{"key":"2877_CR12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1515\/bchm.1998.379.10.1287","volume":"379","author":"JF Wilson","year":"1998","unstructured":"Wilson JF, Erlandsson R. Sexing of human and other primate DNA. Biol Chem. 1998;379:1287\u20138.","journal-title":"Biol Chem"},{"key":"2877_CR13","doi-asserted-by":"publisher","first-page":"244ra91","DOI":"10.1126\/scitranslmed.3008970","volume":"6","author":"S Rebouissou","year":"2014","unstructured":"Rebouissou S, Bernard-Pierrot I, de Reyni\u00e8s A, Lepage ML, Krucker C, Chapeaublanc E, et al. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype. Sci Transl Med. 2014;6:244ra91.","journal-title":"Sci Transl Med"},{"key":"2877_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.celrep.2014.10.035","volume":"9","author":"A Biton","year":"2014","unstructured":"Biton A, Bernard-Pierrot I, Lou Y, Krucker C, Chapeaublanc E, Rubio-P\u00e9rez C, et al. Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes. Cell Rep. 2014;9:1235\u201345.","journal-title":"Cell Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2877-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2877-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2877-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T04:14:04Z","timestamp":1657599244000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2877-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2877"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2877-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]},"article-number":"837"}}